1. Home
  2. LSTA vs FRSX Comparison

LSTA vs FRSX Comparison

Compare LSTA & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • FRSX
  • Stock Information
  • Founded
  • LSTA 1980
  • FRSX N/A
  • Country
  • LSTA United States
  • FRSX Israel
  • Employees
  • LSTA N/A
  • FRSX N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • FRSX Computer Software: Prepackaged Software
  • Sector
  • LSTA Health Care
  • FRSX Technology
  • Exchange
  • LSTA Nasdaq
  • FRSX Nasdaq
  • Market Cap
  • LSTA 24.1M
  • FRSX 9.0M
  • IPO Year
  • LSTA N/A
  • FRSX 2017
  • Fundamental
  • Price
  • LSTA $2.61
  • FRSX $0.55
  • Analyst Decision
  • LSTA Strong Buy
  • FRSX
  • Analyst Count
  • LSTA 1
  • FRSX 0
  • Target Price
  • LSTA $15.00
  • FRSX N/A
  • AVG Volume (30 Days)
  • LSTA 15.8K
  • FRSX 544.6K
  • Earning Date
  • LSTA 08-11-2025
  • FRSX 08-08-2025
  • Dividend Yield
  • LSTA N/A
  • FRSX N/A
  • EPS Growth
  • LSTA N/A
  • FRSX N/A
  • EPS
  • LSTA N/A
  • FRSX N/A
  • Revenue
  • LSTA $1,000,000.00
  • FRSX $436,000.00
  • Revenue This Year
  • LSTA N/A
  • FRSX N/A
  • Revenue Next Year
  • LSTA N/A
  • FRSX N/A
  • P/E Ratio
  • LSTA N/A
  • FRSX N/A
  • Revenue Growth
  • LSTA N/A
  • FRSX N/A
  • 52 Week Low
  • LSTA $1.87
  • FRSX $0.45
  • 52 Week High
  • LSTA $4.20
  • FRSX $2.63
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 50.61
  • FRSX 51.99
  • Support Level
  • LSTA $2.36
  • FRSX $0.45
  • Resistance Level
  • LSTA $3.07
  • FRSX $0.52
  • Average True Range (ATR)
  • LSTA 0.23
  • FRSX 0.04
  • MACD
  • LSTA 0.02
  • FRSX 0.01
  • Stochastic Oscillator
  • LSTA 37.50
  • FRSX 79.25

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: